Clinical practice of whole-genome sequencing in the rapid diagnosis of critically ill neonates.
10.7499/j.issn.1008-8830.2210096
- Author:
Fei-Fan XIAO
1
;
Yu-Lan LU
1
;
Bing-Bing WU
1
;
Xin-Ran DONG
1
;
Guo-Qiang CHENG
;
Li-Yuan HU
;
Wen-Hao ZHOU
1
;
Xiao-Min PENG
1
;
Lin YANG
1
;
Hui-Jun WANG
1
Author Information
1. Center for Molecular Medicine, Children's Hospital of Fudan University/National Children's Medical Center, Shanghai 201102, China.
- Publication Type:Journal Article
- Keywords:
Critical illness;
Genetic disease;
Neonate;
Whole-genome sequencing
- MeSH:
Infant, Newborn;
Male;
Child;
Female;
Humans;
Critical Illness;
Prospective Studies;
Premature Birth;
Dyspnea;
Fever
- From:
Chinese Journal of Contemporary Pediatrics
2023;25(2):135-139
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To explore the application of whole-genome sequencing (WGS) in the rapid clinical diagnosis of critically ill neonates.
METHODS:The critically ill neonates who admitted to the neonatal intensive care unit of Children's Hospital of Fudan University and underwent WGS from August to September, 2019 were enrolled in this prospective study. The genetic testing results and clinical outcome were analyzed with reference to the sequencing data and clinical features of the neonates.
RESULTS:A total of 15 neonates were tested, among whom there were 9 boys and 6 girls. The main reason for hospitalization included abnormal breathing in 7 neonates, poor response in 2 neonates, feeding difficulty in 2 neonates, fever in 1 neonate, hypothermia in 1 neonate, preterm birth in 1 neonate, and convulsion in 1 neonate. The mean turn-around time was 4.5 days for WGS. Finally a genetic diagnosis was obtained for 3 neonates, with a positive diagnostic rate of 20% (3/15). Among the 3 neonates, 2 neonates were withdrawn from the treatment due to severe conditions and 1 neonate died on the day when the sample was sent for genetic testing, whose etiology could be explained by the results of genetic testing.
CONCLUSIONS:WGS technique can provide a timely and effective diagnosis for critically ill neonates suspected of genetic diseases and provide genetic evidence for clinical treatment of critically ill cases.
